ADVANCED BILIARY TRACT CANCER
Clinical trials for ADVANCED BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat bile duct cancer when standard therapy fails
Disease control OngoingThis study is testing whether a combination of three chemotherapy drugs can help control advanced bile duct or gallbladder cancer that has worsened after initial treatment. It will involve about 48 adults whose cancer progressed despite standard chemotherapy. The main goal is to …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
New drug combo tested for Tough-to-Treat bile duct cancer
Disease control OngoingThis study is testing whether combining the drugs lenvatinib and paclitaxel can help control advanced bile duct cancer in patients whose disease got worse after standard gemcitabine-based chemotherapy. It aims to see if this combination can shrink tumors and delay cancer growth. …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug duo tested for Tough-to-Treat bile duct cancer
Disease control OngoingThis study is testing whether combining two drugs, regorafenib and durvalumab, can help control advanced bile duct cancer that has continued to grow after standard chemotherapy. It is for up to 40 patients whose cancer has worsened despite one prior treatment. The main goals are …
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Mar 23, 2026 15:20 UTC
-
Hope for rare cancers: Two-Drug combo trial seeks to control tough tumors
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs (ipilimumab and nivolumab) can help control advanced rare cancers that have shown some sensitivity to these treatments before. It will involve 240 adults with specific rare cancers, including certain neuroendo…
Matched conditions: ADVANCED BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC